SIEGALL CLAY B - Insider Non-Derivative Transactions at Immunome Inc. (IMNM) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Dec 30, 2025, SIEGALL CLAY B's relationship to Immunome Inc. (IMNM) is Director,Officer (President and CEO), and currently has 665,254 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other IMNM insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

SIEGALL CLAY B - Insider Non-Derivative Transactions of IMNM Common Stock

SIEGALL CLAY B - Insider Non-Derivative Transactions at IMNM

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Dec 31, 2025	P -- (Common Stock)	4729	21.15	665254
Dec 20, 2025	G -- (Common Stock)	200000	0	660525
Dec 20, 2025	P -- (Common Stock)	7278	20.48	860525
Dec 19, 2025	P -- (Common Stock)	46511	21.5	853247
Mar 27, 2025	P -- (Common Stock)	137100	7.29	806736
Feb 1, 2025	P -- (Common Stock)	150000	7.75	669636
Nov 23, 2024	P -- (Common Stock)	33943	9.78	519636
Nov 22, 2024	P -- (Common Stock)	66057	9.54	485693
May 22, 2024	P -- (Common Stock)	20434	13.78	419636
May 21, 2024	P -- (Common Stock)	79566	13.91	399202
Oct 3, 2023	P -- (Common Stock)	169204	5.91	319636